HopeStage
Back to overview

Depression studies

Topics
More filters

Depression

Depression involves persistent low mood or loss of interest, often with tiredness and changes in sleep or appetite.

7264studies shown
Showing 1,321-1,332 of 7,264
Behavioral study icon
RecruitingNCT07163013

Digital CBT for Chinese adolescents with depressive symptoms

About this title

Digital Cognitive Behavioral Therapy for Chinese Adolescents With Depressive Symptoms(CADS-D )

Read the official source — NCT07163013
Official study title

Digital Cognitive Behavioral Therapy for Chinese Adolescents With Depressive Symptoms(CADS-D ): A Randomized Clinical Trial

In Chongqing
DepressionInterventional studyAges 12–18
Countries
China
Sponsor
First Affiliated Hospital of Chongqing Medical University
Drug study icon
Not Yet RecruitingNCT06382389

Efficacy of EMONO as an add-on Therapy to Conventional Antidepressants for Depressive Symptoms in Nursing-home Residents With Neurocognitive Disorders: a Controlled study-

Official study title

Efficacy of EMONO as an add-on Therapy to Conventional Antidepressants for the Treatment of Depressive Symptoms in Nursing-home Residents With Neurocognitive Disorders: a Randomized Controlled Trial

This study isn't recruiting yet.

Location not clearly listed
DepressionMedication studyAges 60+
Countries
Sponsor
University Hospital, Tours
Behavioral study icon
Not Yet RecruitingNCT07415850

The Effect of a Four-Week Hatha Yoga Intervention to Improve Quality of Life, Anxiety, and Depressive Symptoms in Individuals Undergoing Assisted Reproductive Technology (ART) Treatment

Official study title

The Effect of a Four-Week Hatha Yoga Intervention to Improve Quality of Life, Anxiety, and Depressive Symptoms in Individuals Undergoing Assisted Reproductive Technology (ART) Treatment: A Randomized Controlled Trial

This study isn't recruiting yet.

In Villanova
Depression, AnxietyBehavioural studyAges 18+
Countries
United States
Sponsor
Villanova University
Drug study icon
CompletedNCT07053345

Esketamine Nasal Spray for treatment-resistant depression

Official study title

An Interventional, Open-label, Single Arm, Multicenter Study to Evaluate the Efficacy and Safety of Esketamine Nasal Spray in Korean Participants With Treatment-Resistant Depression(TRD)

This study has finished and is no longer accepting participants.

Multiple locations, including Goyang Si Gyeonggi Do
DepressionMedication studyAges 18–64
Countries
South Korea
Sponsor
Janssen Korea, Ltd., Korea
Drug study icon
CompletedNCT04080752

JNJ-61393215 for depression

What is this study about?

This study evaluated the safety and effectiveness of JNJ-61393215 for people with depression.

This study has finished and is no longer accepting participants.

Multiple locations, including Garden Grove
DepressionMedication studyAges 18–64
Countries
United States, United Kingdom, Moldova, + 2 others
Sponsor
Janssen Research & Development, LLC
Drug study icon
CompletedNCT05593029

A study of the Safety and Efficacy of SEP-363856 in the Treatment of Adults With Major Depressive Disorder

What is this study about?

This study evaluated the safety and effectiveness of SEP-363856 for people with depression.

This study has finished and is no longer accepting participants.

Multiple locations, including Birmingham
DepressionMedication studyAges 18–65
Countries
United States, Canada, Bulgaria, + 4 others
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc. (Pharmaceutical company)

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.